BIOMAT Database Logo BIOMAT Database Logo

Synthesis and CNS activities of 2-methyl/5-chloro-8-(3-substituted propoxy)quinolines. 2002

J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
Department of Pharmaceutical Chemistry, Vel's College of Pharmacy, Chennai, India.

In the present study, a series of 2-methyl/5-choloro-8-(3-substituted propoxy) quinolines were synthesized. The compounds were characterized by IR, 1H-NMR and elemental analysis. The compounds were investigated for anticonvulsant and decrease in the elevated motor activity by introceptive chemical stimuli (amphetamine antagonistic activity) at the dose level of 80 and 160 mg/kg. Compounds 2, 10, 11, 12 and 13 exhibited significant anticonvulsant and amphetamine antagonistic activity. Compounds 2 and 11 exhibited highest anticonvulsant and amphetamine activity respectively.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011804 Quinolines
D002491 Central Nervous System Agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252) Central Nervous System Drugs
D005260 Female Females
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000697 Central Nervous System Stimulants A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. Analeptic,Analeptic Agent,Analeptic Drug,Analeptics,CNS Stimulant,CNS Stimulants,Central Nervous System Stimulant,Central Stimulant,Analeptic Agents,Analeptic Drugs,Central Stimulants,Agent, Analeptic,Agents, Analeptic,Drug, Analeptic,Drugs, Analeptic,Stimulant, CNS,Stimulant, Central,Stimulants, CNS,Stimulants, Central
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic

Related Publications

J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
Quinolines; the synthesis of 8-substituted 3-methyl-4-(1'-methyl-4'-diethylaminobutylamino)-quinolines.
January 1946, Journal of the American Chemical Society,
J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
Synthesis and CNS activity of 3-substituted 7-chloro-5-phenyl-1,3,4-benzotriazepin-2-ones.
June 1974, Journal of pharmaceutical sciences,
J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
Quinolines; the synthesis of 5- and 7-chloro- and bromo-3-methyl-4-dialkylaminoquinolines.
March 1946, Journal of the American Chemical Society,
J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
Synthesis and CNS activities of some 2-alkyl-3(2-substituted indol-3-yl)-methyl, 6-substituted-quinazolin-4(3H)-ones.
January 1982, Polish journal of pharmacology and pharmacy,
J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
Synthesis and antileishmanial activities of novel 3-substituted quinolines.
March 2005, Antimicrobial agents and chemotherapy,
J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
The synthesis of potential antimalarials; some 2-substituted 8-(3-diethylaminopropylamino)-quinolines.
August 1946, Journal of the American Chemical Society,
J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
November 1992, Pharmaceutical research,
J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
New CNS-active 3-methyl-4-substituted methyl-delta 2-isoxazolin-5-ones.
October 1979, Die Pharmazie,
J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
2-Chloro-8-methyl-quinoline-3-carbaldehyde.
October 2009, Acta crystallographica. Section E, Structure reports online,
J Thomas Leonard, and R Sivakumar, and N Anbalagan, and S Sadishkumar, and S K Sridhar
(2-Chloro-8-methyl-quinolin-3-yl)methanol.
June 2010, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!